Chicago, 27 November 2017 – At the world’s largest radiology conference (RSNA), medical AI company Quantib announced today that it secured €4.5mln ($ 5.4mln) of fresh funding in a round that was lead by Holland Venture and InnovationQuarter. Quantib develops Machine Learning (ML) applications for medical imaging analyses, allowing physicians and researchers to make more efficient and more accurate diagnoses. The investment supports Quantib with her international scale-up ambitions.
Quantib™ Neurodegenerative provides quantification and segmentation of MRI brain scans. It allows you to create and display self-defined views including an overlay of segmented brain tissues and CSF. You can easily download and share a comprehensive report including quantified results of several tissues and CSF.
I welcome the Quantib™ Brain software in our department because it provides robust quantitative imaging biomarkers. It facilitates a more objective way of evaluating and enables detection of subtle abnormalities.
My research focus is to develop technology to optimally exploit information contained in imaging data for improved disease diagnosis and prognosis. Quantib strives to bring this technology to the patient, enabling treatment tailored to the individual and thus realizing the enormous potential of precision medicine.
We push advanced technology forward to make sure radiologists can spend their time in the best way possible. Our engineers go to great lengths to create user-friendly solutions for challenging image analyses issues.